Ballentine Partners’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$636K Buy
5,241
+425
+9% +$51.9K 0.01% 522
2026
Q2
$546K Sell
4,816
-35
-0.7% -$3.47K 0.01% 541
2026
Q1
$457K Sell
4,851
-67
-1% -$6.68K 0.01% 560
2025
Q4
$486K Buy
4,918
+82
+2% +$7.93K 0.01% 516
2025
Q3
$410K Buy
4,836
+12
+0.2% +$949 0.01% 576
2025
Q2
$329K Buy
4,824
+138
+3% +$8.74K ﹤0.01% 654
2025
Q1
$284K Sell
4,686
-649
-12% -$45.3K ﹤0.01% 649
2024
Q4
$368K Buy
5,335
+666
+14% +$47.5K 0.01% 518
2024
Q3
$309K Sell
4,669
-58
-1% -$3.7K 0.01% 573
2024
Q2
$287K Buy
4,727
+182
+4% +$10.3K 0.01% 577
2024
Q1
$259K Buy
4,545
+83
+2% +$4.98K ﹤0.01% 591
2023
Q4
$280K Buy
+4,462
New +$252K 0.01% 521
2023
Q1
– Sell
-2,609
Closed -$210K – 582
2022
Q4
$210K Buy
+2,609
New +$200K 0.01% 451
2017
Q3
– Sell
-1,739
Closed -$232K – 452
2017
Q2
$232K Buy
+1,739
New +$221K 0.02% 320

Other funds holding INCY

Ballentine Partners's INCY Position: Q3 2026 in Review

Ballentine Partners increased its Incyte (INCY) stake by 8.8% in Q3 2026, buying an estimated $51.9K and bringing the position to 5,241 shares worth $636K. The position accounts for 0.01% of the portfolio, ranked #522.

Ballentine Partners first reported a position in INCY in Q2 2017 and has held it in 14 quarters since. 902 funds tracked by Wall St. Rank hold INCY as of Q3 2026.

  • Ballentine Partners held 5,241 shares of Incyte worth $636K as of Q3 2026.
  • Ballentine Partners bought 425 Incyte shares in Q3 2026, an estimated $51.9K.
  • Incyte made up 0.01% of Ballentine Partners's portfolio in Q3 2026, its #522 holding.
  • Ballentine Partners first reported a position in Incyte in Q2 2017 and has held it in 14 quarters since.
  • 902 funds tracked by Wall St. Rank held Incyte as of Q3 2026.

Based on Ballentine Partners's 13F filing for Q3 2026, filed 13 Nov 2026.